FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) from Boehringer Ingelheim Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SPIRIVA RESPIMAT (tiotropium bromide inhalation spray)

Snippet

SUPPL AP for SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE INHALATION SPRAY)